Issuer · CIK 0001936258
NAMS — NewAmsterdam Pharma Co N.V.
Recent filings
- Jul 22, 2026·Form 4·Sell$2.1M
NAMS/NewAmsterdam Pharma Co N.V.
Kooij Louise Frederika · Chief Accounting Officer
Mechanical filing
AI thesis skipped - Jun 24, 2026·Form 4·Sell$1.2M
NAMS/NewAmsterdam Pharma Co N.V.
Kooij Louise Frederika · Chief Accounting Officer
Mechanical filing
AI thesis skipped - Mar 10, 2026·Form 4·Sell$829K
NAMS/NewAmsterdam Pharma Co N.V.
LANGE LOUIS G · director
22conviction - Mar 9, 2026·Form 4·Sell$3.2M
NAMS/NewAmsterdam Pharma Co N.V.
Kastelein Johannes Jacob Pieter · Chief Scientific Officer
8conviction